A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)
Led by Chinese University of Hong Kong · Updated on 2024-01-23
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
Upper Tract Urothelial Cancer (UTUC) is a relatively uncommon but increasingly diagnosed condition with many controversies and limitations in its management. Researchers aim to create a local registry at their hospital to gather detailed clinical information and outcomes related to UTUC, helping to better understand the disease's epidemiology, natural history, and treatment results. This study is observational and focuses on collecting comprehensive data to improve knowledge and care for UTUC patients.
Participants in this study will be adults diagnosed with UTUC who are either awaiting surgery or have a history of UTUC with prior interventions. The study involves collecting blood, urine, and tumor tissue samples to explore new diagnostic and therapeutic possibilities. There is no specific treatment given as part of this study; rather, it tracks patients over time to assess the disease and its effects.
Participants will be followed for up to 10 years to monitor long-term survival, recurrence rates, disease progression, and any complications related to UTUC. The study includes regular collection of clinical information and biological samples to support these assessments. This long-term observation aims to provide valuable insights into the physical and biological impact of UTUC on patients.
CONDITIONS
Brief Title
A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Male patients older than 18 years
Patients diagnosed with Upper Tract Urothelial Cancer and scheduled for surgery
Patients with a history of Upper Tract Urothelial Cancer who have had any intervention
You will not qualify if you...
Patients unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surgery
Duration - Varies depending on individual treatment schedules
Participants undergo surgery as part of their treatment for Upper Tract Urothelial Cancer.
Scheduled surgical visits
Long-term Monitoring
Duration - Up to 10 years
Participants are monitored for long-term survival, recurrence, progression, and complications related to Upper Tract Urothelial Cancer.
Trends in epidemiology and treatment of upper urinary tract tumours in the Netherlands 1995-2005: an analysis of PALGA, the Dutch national histopathology registry.
Evelyne C C Cauberg, Maartje A Salomons, Intan P E D Kümmerlin...